Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · Real-Time Price · USD
3.880
+0.080 (2.11%)
At close: Jun 18, 2025, 4:00 PM
3.880
0.00 (0.00%)
Pre-market: Jun 20, 2025, 5:53 AM EDT
Tivic Health Systems Employees
Tivic Health Systems had 7 employees as of December 31, 2024. The number of employees decreased by 2 or -22.22% compared to the previous year.
Employees
7
Change (1Y)
-2
Growth (1Y)
-22.22%
Revenue / Employee
$73,714
Profits / Employee
-$810,857
Market Cap
3.41M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7 | -2 | -22.22% |
Dec 31, 2023 | 9 | -7 | -43.75% |
Dec 31, 2022 | 16 | 9 | 128.57% |
Dec 31, 2021 | 7 | -1 | -12.50% |
Dec 31, 2020 | 8 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
TIVC News
- 5 weeks ago - Tivic Health Systems Inc. (TIVC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation - Business Wire
- 5 weeks ago - Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission - Business Wire
- 5 weeks ago - Tivic Expands VNS Intellectual Property Portfolio - Business Wire
- 5 weeks ago - Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast - Business Wire
- 2 months ago - Tivic Health Reports White House Briefing and FDA Meetings Secured Positive Interest in Potential Military and Defense Applications of Its Product Candidates - Business Wire
- 2 months ago - Tivic Health Extends its Worldwide License of TLR5 Agonist Entolimod to Include the Treatment of Neutropenia - Business Wire
- 2 months ago - Tivic Health Systems, Inc. Regains Compliance with NASDAQ Minimum Bid Price Listing Rule - Business Wire